Outcome of thyroid function in graves' patients treated with radioiodine: Role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 1, 1998, Pages 40-46

  Chiovato, L ^a   Fiore, E ^a   Vitti, P ^a   Rocchi, R ^a   Rago, T ^a   Dokic, D ^a   Latrofa, F ^a   Mammoli, C ^a   Lippi, F ^a   Ceccarelli, C ^a   Pinchera, A ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; THYROID DISEASE; THYROID FOLLICLE CELL; THYROID FUNCTION; TISSUE INJURY; TREATMENT OUTCOME;

ADULT; AGED; ANTITHYROID AGENTS; AUTOANTIBODIES; FEMALE; FOLLOW-UP STUDIES; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOGLOBULINS, THYROID-STIMULATING; IODINE RADIOISOTOPES; MALE; METHIMAZOLE; MIDDLE AGED; THYROID GLAND; THYROTROPIN; TIME FACTORS;

EID: 14444273438     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.1.40     Document Type: Article

References (24)

1. Singer PA, Cooper DS, Elliot GL, et al. 1995 Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA. 273:808-811.
2. Cooper DS. 1996 Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid. 7th ed. Philadelphia: Lippincott-Raven; 713-733.
3. Marcocci C, Gianchecchi D, Masini I, et al. 1990 A reappraisal of the role of methimazole and other factors on the efficacy and outcome of radioiodine therapy of Graves' hyperthyroidism. J Endocrinol Invest. 13:513-520.
4. Franklyn JA. 1994 The management of hyperthyroidism. N Engl J Med. 330:1731-1738.
5. Chiovato L, Santini F, Pinchera A. 1995 Treatment of hyperthyroidism. Thyroid Int. 2:3-23.
6. Nordyke R, Gilbert FI. 1991 Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease. T Nucl Med. 32:411-416.
7. Maxon HR, Saenger EL. 1996 Biological effects of radioiodine on the human thyroid gland. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid. 7th ed. Philadelphia: Lippincott-Raven; 342-351.
8. Williams ED. 1991 Biological effects of radiation on the thyroid. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid. 6th ed. Philadelphia: Lippincott Co.; 421-436.
9. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. 1996 Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: results of a prospective, randomized, multicentre study. Eur J Clin Invest. 26:59-63.
10. Pinchera A, Liberti P, Martino E, et al. 1969 Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. J Clin Endocrinol Metab. 29:231-238.
11. Atkinson S, McGregor AM, Kendall-Taylor P, Petereon MM, Smith BR. 1982 Effect of radioiodine on stimulatory activity of Graves' immunoglobulins. Clin Endocrinol (Oxf). 16:537-543.
12. Bech K, Bliddal H, Siersbaek-Nielsen K, Friis T. 1982 Production of non-stimulatory immunoglobulins that inhibit TSH binding in Graves' disease after radioiodine administration. Clin Endocrinol (Oxf). 17:395-402.
13. Cho BY, Shong YK, Chung JK, et al. 1989 Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment. Thyroidology. 3:109-114.
14. Michelangeli VP, Poon C, Topliss DJ, Colman PG. 1995 Specific effects of radioiodine treatment on TSAb and TBAb levels in patients with Graves' disease. Thyroid. 5:171-176.
15. Brunn J, Blocjk U, Ruf J, Bos I, Kunze WP, Scriba PC. 1983 Volumetrie der schildrusenlappen mittels real-time sonographie. Dtsch Med Wochenschr. 287:1206-1207.
16. Vitti P, Elisei R, Tonacchera M, et al. 1993 Detection of thyroid-stimulating antibody using Chinese Hamster Ovary cells transfected with the cloned human thyrotropin receptor. J Clin Endocrinol Metab. 76:499-503.
17. Chiovato L, Vitti P, Bendinelli G, et al. 1994 Detection of antibodies blocking thyrotropin effect using Chinese Hamster ovary cells transfected with the cloned human TSH receptor. J Endocrinol Invest. 17:809-816.
18. Murakami Y, Takamatsu J, Sakane S, Kuma K, Ohsawa N. 1996 Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. J Clin Endocrinol Metab. 81:3257-3260.
19. Tsuruta M, Nagayama Y, Yokoyama N, Izumi M, Nagataki S. 1993 Long-term follow-up studies on iodine-131 treatment of hyperthyroid Graves' disease based on the measurement of thyroid volume by ultrasonography. Ann Nucl Med. 7:193-197.
20. 131I therapy for Graves' disease. N Engl J Med. 311:426-432.
21. Aizawa Y, Yoshida K, Kaise N, et al. 1995 Long-term effects of radioiodine on thyrotropin receptor antibodies in Graves' disease. Clin Endocrinol (Oxf). 42:517-522.
22. Vitti P, Chiovato L, Tonacchera M, et al. 1994 Failure to detect thyroid growth-promoting activity in immunoglobulin G of patients with endemic goiter. J Clin Endocrinol Metab. 78:1020-1025.
23. McGregor AM, Petersen MM, Capiferri R, Evered DC, Smith BR, Hall R. 1979 Effects of radioiodine on thyrotropin binding inhibiting immunoglobulins in Graves' disease. Clin Endocrinol (Oxf). 11:437-444.
24. DeGroot LJ. 1997 Radioiodine and the immune system. Thyroid. 7:259-264.